Pharma: Other News To Note
• Baxter International Inc., of Deerfield, Ill., said the European Medicines Agency authorized an update to the summary of product characteristics (smPC) for Advate [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method, or octocog alfa)] to include findings of its Phase IV prophylaxis study, which compared standard and pharmacokinetic (PK)-guided prophylaxis dosing regimens to on-demand treatment with Advate.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST